The potential value of dual-energy CT radiomics in evaluating CD8+, CD163+ and αSMA+ cells in the tumor microenvironment of clear cell renal cell carcinoma.

IF 2.8 3区 医学 Q2 ONCOLOGY
Clinical & Translational Oncology Pub Date : 2025-02-01 Epub Date: 2024-07-31 DOI:10.1007/s12094-024-03637-8
Ruobing Li, Xue Bing, Xinyou Su, Chunling Zhang, Haitao Sun, Zhengjun Dai, Aimei Ouyang
{"title":"The potential value of dual-energy CT radiomics in evaluating CD8<sup>+</sup>, CD163<sup>+</sup> and αSMA<sup>+</sup> cells in the tumor microenvironment of clear cell renal cell carcinoma.","authors":"Ruobing Li, Xue Bing, Xinyou Su, Chunling Zhang, Haitao Sun, Zhengjun Dai, Aimei Ouyang","doi":"10.1007/s12094-024-03637-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This study aims to develop radiomics models and a nomogram based on machine learning techniques, preoperative dual-energy computed tomography (DECT) images, clinical and pathological characteristics, to explore the tumor microenvironment (TME) of clear cell renal cell carcinoma (ccRCC).</p><p><strong>Methods: </strong>We retrospectively recruited of 87 patients diagnosed with ccRCC through pathological confirmation from Center I (training set, n = 69; validation set, n = 18), and collected their DECT images and clinical information. Feature selection was conducted using variance threshold, SelectKBest, and the least absolute shrinkage and selection operator (LASSO). Radiomics models were then established using 14 classifiers to predict TME cells. Subsequently, we selected the most predictive radiomics features to calculate the radiomics score (Radscore). A combined model was constructed through multivariate logistic regression analysis combining the Radscore and relevant clinical characteristics, and presented in the form of a nomogram. Additionally, 17 patients were recruited from Center II as an external validation cohort for the nomogram. The performance of the models was assessed using methods such as the area under the receiver operating characteristic curve (AUC), calibration curve, and decision curve analysis (DCA).</p><p><strong>Results: </strong>The validation set AUC values for the radiomics models assessing CD8<sup>+</sup>, CD163<sup>+</sup>, and αSMA<sup>+</sup> cells were 0.875, 0.889, and 0.864, respectively. Additionally, the external validation cohort AUC value for the nomogram reaches 0.849 and shows good calibration.</p><p><strong>Conclusion: </strong>Radiomics models could allow for non-invasive assessment of TME cells from DECT images in ccRCC patients, promising to enhance our understanding and management of the tumor.</p>","PeriodicalId":50685,"journal":{"name":"Clinical & Translational Oncology","volume":" ","pages":"716-726"},"PeriodicalIF":2.8000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical & Translational Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12094-024-03637-8","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/31 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: This study aims to develop radiomics models and a nomogram based on machine learning techniques, preoperative dual-energy computed tomography (DECT) images, clinical and pathological characteristics, to explore the tumor microenvironment (TME) of clear cell renal cell carcinoma (ccRCC).

Methods: We retrospectively recruited of 87 patients diagnosed with ccRCC through pathological confirmation from Center I (training set, n = 69; validation set, n = 18), and collected their DECT images and clinical information. Feature selection was conducted using variance threshold, SelectKBest, and the least absolute shrinkage and selection operator (LASSO). Radiomics models were then established using 14 classifiers to predict TME cells. Subsequently, we selected the most predictive radiomics features to calculate the radiomics score (Radscore). A combined model was constructed through multivariate logistic regression analysis combining the Radscore and relevant clinical characteristics, and presented in the form of a nomogram. Additionally, 17 patients were recruited from Center II as an external validation cohort for the nomogram. The performance of the models was assessed using methods such as the area under the receiver operating characteristic curve (AUC), calibration curve, and decision curve analysis (DCA).

Results: The validation set AUC values for the radiomics models assessing CD8+, CD163+, and αSMA+ cells were 0.875, 0.889, and 0.864, respectively. Additionally, the external validation cohort AUC value for the nomogram reaches 0.849 and shows good calibration.

Conclusion: Radiomics models could allow for non-invasive assessment of TME cells from DECT images in ccRCC patients, promising to enhance our understanding and management of the tumor.

Abstract Image

双能 CT 放射组学在评估透明细胞肾细胞癌肿瘤微环境中 CD8+、CD163+ 和 αSMA+ 细胞方面的潜在价值。
目的:本研究旨在开发基于机器学习技术、术前双能计算机断层扫描(DECT)图像、临床和病理特征的放射组学模型和提名图,以探索透明细胞肾细胞癌(ccRCC)的肿瘤微环境(TME):我们回顾性地从I中心招募了87名经病理确诊的ccRCC患者(训练集,n = 69;验证集,n = 18),并收集了他们的DECT图像和临床信息。使用方差阈值、SelectKBest和最小绝对收缩与选择算子(LASSO)进行特征选择。然后使用 14 个分类器建立放射组学模型来预测 TME 细胞。随后,我们选择了最具预测性的放射组学特征来计算放射组学得分(Radscore)。通过多变量逻辑回归分析,结合 Radscore 和相关临床特征,构建了一个综合模型,并以提名图的形式呈现。此外,还从第二中心招募了 17 名患者作为提名图的外部验证队列。使用接收者操作特征曲线下面积(AUC)、校准曲线和决策曲线分析(DCA)等方法对模型的性能进行了评估:结果:评估 CD8+、CD163+ 和 αSMA+ 细胞的放射组学模型的验证集 AUC 值分别为 0.875、0.889 和 0.864。此外,提名图的外部验证队列 AUC 值达到 0.849,显示出良好的校准性:放射组学模型可以通过 DECT 图像对 ccRCC 患者的 TME 细胞进行无创评估,有望增强我们对肿瘤的了解和管理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.20
自引率
2.90%
发文量
240
审稿时长
1 months
期刊介绍: Clinical and Translational Oncology is an international journal devoted to fostering interaction between experimental and clinical oncology. It covers all aspects of research on cancer, from the more basic discoveries dealing with both cell and molecular biology of tumour cells, to the most advanced clinical assays of conventional and new drugs. In addition, the journal has a strong commitment to facilitating the transfer of knowledge from the basic laboratory to the clinical practice, with the publication of educational series devoted to closing the gap between molecular and clinical oncologists. Molecular biology of tumours, identification of new targets for cancer therapy, and new technologies for research and treatment of cancer are the major themes covered by the educational series. Full research articles on a broad spectrum of subjects, including the molecular and cellular bases of disease, aetiology, pathophysiology, pathology, epidemiology, clinical features, and the diagnosis, prognosis and treatment of cancer, will be considered for publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信